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Abstract
Background: A nonsurgical intervention, interventional microadhesiolysis, was developed to
release adhesions in joints and soft tissues. This paper introduces the procedure and evaluates the
efficacy of the intervention for adhesive capsulitis of the shoulder.
Methods: Ten patients (five men and five women) with primary adhesive capsulitis of the shoulder
were treated at a chronic pain management center in Korea. Three specially made needles are used
in interventional microadhesiolysis: the Round, Flexed Round, and Ahn's needles. A Round Needle
is inserted on the skin over middle of supraspinatus and advanced under the acromion and
acromioclavicular joint (subacromial release). A Flexed Round Needle is inserted two-fingers
caudal to the inferior border of the scapular spine and advanced over the capsule sliding on the
surface of infraspinatus muscle-tendon fascia. The capsule is released while an assistant
simultaneously passively abducts the shoulder to full abduction (posteroinferior capsule release).
An Ahn's Needle is inserted on the skin over the lesser tubercle and advanced under the coracoid
process sliding on the surface of the subscapularis muscle (subcoracoid release).
Results: After the patients underwent interventional microadhesiolysis, the self-rated pain score
or severity declined significantly (p < .01), the shoulder range of motion increased significantly (p <
.01), and joint effusion in the affected shoulder decreased or disappeared in nine of ten patients on
magnetic resonance imaging compared to their initial status.
Conclusion: Our findings suggest that interventional microadhesiolysis is effective for managing
adhesive capsulitis of the shoulder.
Background
Adhesive capsulitis of the shoulder is characterized by
pain in the shoulder and limitation of glenohumeral
movement. It tends to occur in patients older than 40
years of age and most commonly in females in their 50s.
It has been reported that adhesive capsulitis lasts 2–3
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years [1]. Even after this period, however, resolution may
not be complete, and many studies have shown mild to
moderate restriction of motion [2].
Various interventions have been developed to treat this
annoying condition, including oral medication, corticos-
teroid injection, physical therapy, nerve blocks, manipu-
lation under anesthesia, distension arthrography, and
surgical or arthroscopic release [3-8].
Evidence exists that the pathological changes underlying
adhesive capsulitis involve synovial inflammation with
subsequent reactive capsular fibrosis, which is the ulti-
mate course of adhesive capsulitis irrespective of the
underlying cause [9]. Therefore, it is imperative that adhe-
sions that affect the joint be released. Distension arthrog-
raphy and surgical or arthroscopic release procedures have
been used for this. However, the limitations of these pro-
cedures should be considered: readhesion can result from
bleeding or oozing during or after the procedure; inter-
vention-related risks, such as bleeding, infection, and pain
after procedures, can occur [10]. Despite these limitations,
however, randomized controlled trials have provided lit-
tle evidence to support or dispute the efficacy of these
interventions [11].
A nonsurgical intervention, interventional microadhesiolysis,
was developed to release adhesions in joints and soft tis-
sues. The procedure has been used to relieve adhesive cap-
sulitis of the shoulder. The objectives of this study were to
introduce this procedure and evaluate the efficacy of the
intervention for adhesive capsulitis of the shoulder.
Methods
Subjects
Ten patients (five men and five women) with primary
adhesive capsulitis of the shoulder were treated at a
chronic pain management center in the Republic of Korea
between 2005 and 2006. The diagnosis of primary adhe-
sive capsulitis in the subjects was made by an expert in
pain management based on the medical history and phys-
ical examination, i.e., pain in the shoulder and global loss
of glenohumeral movement without underlying patholo-
gies such as diabetes mellitus, previous upper extremity
fracture, surgery with immobilisation, or stroke.
The average age of the subjects was 56.0 ± 7.9 years: 59.0
± 8.9 years for the males and 53.0 ± 6.3 for the females.
The average pain duration in the subjects was 6.2 ± 2.9
months: 5.0 ± 1.4 months in males and 7.4 ± 3.6 months
in females. The adhesive capsulitis affected the left shoul-
der in four patients (two men and two women) and the
right shoulder in six (three men and three women). Table
1 summarizes the patient profile. The Institutional Review
Board of Kangnam Cha Hospital, Pochon Cha University,
approved the study protocol, and all of the subjects gave
informed consent.
Needles
The needles used in interventional microadhesiolysis are
shown in Figure 1. They are the Round (Figure 1a), Flexed
Round (Figure 1d), and Ahn's (Figure 1g) needles
(Hansung Precision, Anyang, Korea). The latter was
named after the developer. The Round and Flexed Round
needles are 1.2 mm in diameter and 80 mm long. Ahn's
Needle is 0.7 mm in diameter and 65 mm long. The
Flexed Round Needle is similar to the Round Needle, but
its tip is flexed. Ahn's Needle is similar to the Round Nee-
dle, but has a syringe-like appearance, with scales on the
Table 1: Profiles of the patients who underwent interventional microadhesiolysis
Glenohumeral ROM Pre-interventional MRI finding
Patient Age (years) Sex Affected 
shoulder
Pain duration 
(months)
Abd (deg) ER (deg) IR (deg) Joint effusion* Thickness of the joint 
capsule/synovium (mm)
Stage¶
1 56 F Right 6 90 30 15 ++ 9.1 3
2 49 M Right 4 75 30 15 + 4.9 2
35 7 F L e f t 3 9 0 3 0 1 5 + + 5 . 3 2
4 51 M Right 6 80 30 15 ++ 7.0 3
54 4 F L e f t 1 2 8 0 4 5 3 0 + 5 . 6 3
6 60 M Right 6 90 30 15 ++ 7.6 3
7 49 F Right 6 90 45 15 ++ 4.8 2
8 59 F Right 10 90 30 15 ++ 4.2 2
96 6 M L e f t 3 9 0 3 0 1 5 + 5 . 0 2
10 69 M Left 6 90 30 15 ++ 5.0 2
ROM, range of motion; Abd, abduction; ER, external rotation; IR; internal rotation.
* '+' indicates minimal joint effusion; '++' indicates moderate joint effusion.
¶The stage of adhesive capsulitis was designated according to Hannafin and Chiaia (2000).BMC Musculoskeletal Disorders 2008, 9:12 http://www.biomedcentral.com/1471-2474/9/12
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surface of syringe, and it is thinner and shorter than the
Round Needle. Use of these specially made needles is the
unique feature of this technique.
In medicine, hollow injection needles are generally used
to administer medications into tissues. They are rigid and
inflexible, penetrating tissues that are softer than the nee-
dle or are stopped if the tissues are harder, which can dam-
age the tissues. Therefore, a new type of needles was
developed for interventional microadhesiolysis. They are
streamlined, solid, flexible, and have blunt round tips
(Figure 1(b),(c),(e),(f),(h),(i)). They were derived from
the needle used in intramuscular stimulation (IMS) devel-
oped by Gunn [12]. The IMS needle is used to penetrate
and release deep contractures. Gunn insists that stimula-
tion by IMS needle lasts for several days and it promotes
healing by the release of the platelet derived growth factor
[13]. The needles used in interventional microadhesioly-
sis are thicker than IMS needle (diameter 0.30–0.35 mm)
and more rigid, but have flexibility. They have been
awarded a patent in Korea (Patent No. 10-2004-41689).
Procedure
Interventional microadhesiolysis for adhesive capsulitis
involves three release approaches: subacromial release,
posteroinferior capsule release, and subcoracoid release.
The Round Needle is used for the subacromial release, the
Flexed Round Needle for the posteroinferior capsule
release, and Ahn's needle for the subcoracoid release.
First, the patient is asked to lie on a table in the prone
position and is sedated with intravenous propofol
(Diprivan®, 2–2.5 mg/kg for induction and 100–200 μg/
kg/min for maintenance) to avoid pain during the proce-
dure.
Figure 2 shows the subacromial release procedure. A
Round Needle is inserted on the skin over middle of
supraspinatus of the affected shoulder and advanced
under the acromion and acromioclavicular joint (Figure
2(a),(b)). The needle is moved forward and backward,
sliding on the surface of the supraspinatus muscle-tendon
fascia along the subacromial space and under the acromi-
oclavicular joint until no resistance is felt at the tip of the
needle. When no resistance is felt, this procedure is fin-
ished.
Figure 3 shows the posteroinferior capsule release proce-
dure. A Flexed Round Needle is inserted two fingers cau-
dal to the inferior border of the scapular spine and
advanced over the posterior capsule, sliding on the surface
The subacromial release procedure in interventional micro- adhesiolysis for adhesive capsulitis of the shoulder Figure 2
The subacromial release procedure in interventional micro-
adhesiolysis for adhesive capsulitis of the shoulder. (a) A 
Round Needle inserted at the superior scapular spine of the 
shoulder beneath the acromion on the surface of the 
supraspinatus muscle in a human skeleton model; (b) A 
Round Needle inserted in a patient; (c) The position of the 
Round Needle inserted in the patient could be identified on 
fluoroscopy; (d) The injection of diluted triamcinolone aceto-
nide (0.4 mg/ml) after completion of the release to prevent 
readhesion.
The needles used in interventional microadhesiolysis Figure 1
The needles used in interventional microadhesiolysis. (a) The 
Round Needle and close-ups of its tip from above (b) and the 
side (c); (d) The Flexed Round Needle and close-ups of its tip 
from above (e) and the side (f); (g) Ahn's Needle and close-
ups of its tip from above (h) and the side (i).BMC Musculoskeletal Disorders 2008, 9:12 http://www.biomedcentral.com/1471-2474/9/12
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of the infraspinatus muscle-tendon fascia (Figure
3(a),(c)). The needle is moved forward and backward over
the posterior capsule until about 90° of abduction is
achieved. After 90° of abduction is achieved, the needle is
inserted two fingers caudal to the first insertion point, tar-
geting the axillary recess, and also moved forward and
backward. While the operator releases the capsular fibro-
sis using the Flexed Round Needle under ultrasono-
graphic guidance, an assistant gently abducts the shoulder
to the point at which no resistance is felt, as obtained with
release of the capsular fibrosis. This release and passive
abduction process is performed simultaneously, and the
degree of abduction is increased gradually (Figure
3(b),(d)). When full abduction of the affected shoulder is
achieved, this procedure is finished.
Figure 4 shows the subcoracoid release procedure. After
the posteroinferior capsule is released, the patient is
The subcoracoid release procedure in interventional micro- adhesiolysis for adhesive capsulitis of the shoulder Figure 4
The subcoracoid release procedure in interventional micro-
adhesiolysis for adhesive capsulitis of the shoulder. (a) Posi-
tions of the shoulder and elbow during the subcoracoid 
release procedure, shown using a human skeleton model. 
The patient's shoulder is adducted, externally rotated, and 
extended 15–30°, and the elbow is extended; (b) An Ahn's 
Needle inserted in the skin over the lesser tubercle of the 
humerus and advanced under the coracoid process, sliding 
on the surface of the subscapularis muscle in a human skele-
ton model; (c) An Ahn's Needle inserted in a patient under 
ultrasonographic guidance; (d) Ultrasonographic finding of 
the subcoracoid release procedure; (e) A linear ultrasound 
probe wrapped in a sterile surgical glove to prevent contami-
nation.
The posteroinferior capsule release procedure in interven- tional microadhesiolysis for adhesive capsulitis of the shoul- der Figure 3
The posteroinferior capsule release procedure in interven-
tional microadhesiolysis for adhesive capsulitis of the shoul-
der. (a) A Flexed Round Needle inserted below the inferior 
border of the scapular spine on the infraspinatus muscle-ten-
don fascia in a human skeleton model; (b) Release of capsular 
fibrosis using the Flexed Round Needle in a human skeleton 
model; (c) A Flexed Round Needle inserted in a patient; (d) 
Release of the capsular fibrosis using the Flexed Round Nee-
dle and with simultaneous passive abduction by an assistant; 
Fluoroscopic images of a Flexed Round Needle inserted in a 
patient at (e) 45° of abduction and (f) near full abduction; (g) 
Longitudinal ultrasound image of a Flexed Round Needle 
inserted in a patient; (h) Transverse ultrasound image of a 
Flexed Round Needle inserted in a patient.BMC Musculoskeletal Disorders 2008, 9:12 http://www.biomedcentral.com/1471-2474/9/12
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moved to the supine position. The patient's shoulder is
adducted, externally rotated, and extended 15–30°, and
the elbow is extended (Figure 4(a)). An Ahn's Needle is
inserted through the skin over the lesser tubercle of the
humerus and advanced under the coracoid process under
ultrasonographic guidance (Figure 4(b),(c)). The needle is
moved forward and backward under the coracoid process
and on the surface of the subscapularis muscle until no
resistance is felt at the tip of the needle. When full internal
and external rotation is achieved, all the release proce-
dures have been successfully accomplished.
Fluoroscopy (Figure 2(c), 3(e),(f)) and ultrasonography
(Figure 3(g),(h), 4(d)) are used to check the position of
the needles and guide them. When using ultrasonogra-
phy, a linear ultrasound probe is wrapped in a sterile sur-
gical glove to prevent contamination (Figure 4(e)). For
proper delivery of ultrasound, ultrasound gel is applied
between the linear probe and the surgical glove. Sterile
ultrasound gel (Aquasonic® 100) is applied between the
skin of the patient and the surgical glove. The ultrasound
gel applied between the linear probe and the surgical
glove does not need to be sterile, but that applied between
skin of the patient and the surgical glove should be sterile.
After completing each phase of the release, about 5 ml of
diluted triamcinolone acetonide (0.4 mg/ml) is intro-
duced along each microadhesiolysis route to prevent read-
hesion after the procedure (Figure 2(d)). The solution is
made by diluting one vial of triamcinolone acetonide (40
mg) with 100 ml normal saline, which is 1/100 of the
usual concentration used in steroid injection therapy.
After the patients undergo the initial intervention, their
pain level and range of motion (ROM) are evaluated every
3 weeks. If the patient complains of persistent pain or lim-
ited ROM, the intervention is repeated 3 weeks later.
Outcome measures
We selected three outcome measures to evaluate the treat-
ment effect of interventional microadhesiolysis in adhe-
sive capsulitis: the self-rated pain score or severity, the
glenohumeral ROM of the affected shoulder, and mag-
netic resonance imaging (MRI) of the affected shoulder.
These measures were assessed before and after the inter-
vention.
The patients were asked to rate their overall pain level
using a visual analogue scale (VAS) consisting of a 10-cm
line anchored by two extremes of pain. They were also
asked to rate the severity of pain at night, during rest, and
on activity to evaluate the pain level in specific situations.
The severity was described as 1 = none, 2 = mild, 3 = mod-
erate, 4 = severe, or 5 = very severe pain.
Glenohumeral ROM was measured with the patients in a
supine position. To measure glenohumeral internal rota-
tion, the humerus was kept in maximal allowable abduc-
tion with the elbow flexed 90° while the examiner's hand
prevented the scapula from elevating or tilting anteriorly.
The forearm was taken toward the supporting surface of
the examining table with the palm facing toward the
examining table, moving the extremity into internal rota-
tion. Once a firm end point was felt, the ROM was meas-
ured. External rotation ROM was taken from the same
starting position as for the internal rotation ROM meas-
urement. In this measurement, the forearm was taken pos-
teriorly so that the extensor surface of the forearm was
moved toward the head of the examining table [14]. The
final self-rated pain score or severity and ROM were eval-
uated 3 months after the initial intervention.
The patients were also examined with a 1.0-T MRI unit
(Magnum 1.0T; Medinus, Seoul, Korea). Axial, oblique
sagittal, oblique coronal T2-weighted (TR 3500 ms, TE 96
ms), and proton density-oblique coronal or proton den-
sity-axial images were evaluated. We did not perform MR
arthrography using intra-articular contrast injection
because the patients did not want to undergo an invasive
diagnostic procedure before they underwent the invasive
treatment, i.e., interventional microadhesiolysis. The radi-
ological diagnosis was based on reported MR findings in
adhesive capsulitis [15-17]: thickening of the inferior
glenohumeral ligament (IGHL) at the axillary pouch level,
the thickness of the joint capsule and synovium, and the
amount of joint effusion.
Thickening of the IGHL and a minimal or moderate joint
effusion were detected on the MRI obtained before inter-
vention. The thickness of the joint capsule and synovium
was measured on the oblique coronal T2-weighted image.
The minimum thickness was 4.2 mm and the maximum
was 9.1 mm (Table 1). An independent radiologist who
had no conflict of interest evaluated the MRI findings in
the patients. The follow-up MRI was taken 9.0 ± 3.0
months (range 3–13 months) after the initial interven-
tion.
Wilcoxon's signed-ranks test was used to evaluate the sta-
tistical significance of the mean pre- and post-interven-
tional self-rated pain score or severity and the ROM of the
affected shoulder. The MRIs of the affected shoulder taken
before and after intervention were compared.
Results
After the patients underwent interventional microadhesi-
olysis, their self-rated pain score or severity declined sig-
nificantly compared to their initial status (p < .01). Their
mean VAS pain score decreased 5.2 ± 2.0 points (range
2–8 points). The severity of pain at night decreased 3.0 ±BMC Musculoskeletal Disorders 2008, 9:12 http://www.biomedcentral.com/1471-2474/9/12
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1.3 points (range 0–4 points), that at rest decreased 1.2 ±
0.8 points (range 0–2 points), and that on activity
decreased 1.8 ± 0.6 points (range 1–3 points). Conversely,
the ROM increased significantly (p < .01). The angle of
abduction increased 85.5 ± 15.0° (range 60–105°), that
of external rotation increased 44.5 ± 18.8° (range
15–60°), and that of internal rotation increased 33.0 ±
9.5° (range 15–45°) (Table 2).
The joint effusion in the affected shoulder decreased or
disappeared in nine of ten patients following interven-
tional microadhesiolysis on the follow-up MRI. It was the
most obvious MRI finding after intervention among the
patients (Figure 5). However, no significant change was
noted in the IGHL thickness. We could not measure the
thickness of the joint capsule or synovium on the follow-
up MRI because the joint effusion decreased or disap-
peared.
The patients underwent an average of 1.8 ± 0.6 interven-
tions (range 1–3). Except for the pain after waking follow-
ing sedation, no significant or fatal adverse effect was
noted. Fentanyl 50 μg/h patch (Durogesic® D Trans) was
prescribed to the patients who complained of severe pain
after waking.
Discussion
After the patients underwent interventional microadhesi-
olysis, the self-rated pain score or severity declined signif-
icantly (p  < .01), the ROM of the affected shoulder
increased significantly (p < .01), and the joint effusion in
the affected shoulder decreased or disappeared in nine of
ten patients on MRI compared to their initial status. These
results suggest that interventional microadhesiolysis is
effective for managing adhesive capsulitis of the shoulder.
We used interventional microadhesiolysis clinically after
we confirmed its safety and effectiveness in a cadaveric
examination. The shoulders of cadavers are stiff irrespec-
tive of the presence of adhesive capsulitis before death.
We used needles following our described procedure and
confirmed that the technique did not cause serious dam-
age and that the shoulders became movable.
Our technique does not include an intra-articular
approach. It aims to release the structures that cause sig-
nificant loss of ROM of the shoulder. It does not aim to
release the entire capsule because most studies do not
describe significant capsular adhesion as a predominant
finding in adhesive capsulitis. Although the glenohumeral
joint synovial capsule is often involved in adhesive capsu-
litis, most of the significant loss of ROM results from
pathology in structures outside of the glenohumeral joint
synovial capsule (e.g., coracohumeral ligament, rotator
interval, subscapularis muscle, and subacromial bursa)
[18]. The posteroinferior capsule was selected for release
because the most significant capsular adhesion is
observed in this area in patients with adhesive capsulitis
[15-17]. The assistant was required to abduct the shoulder
to keep the capsule stretched during the posteroinferior
capsule release procedure. Adhesions can be released
using a needle when the target tissue is stretched. The
Magnetic resonance images (MRI) of a patient before and  after interventional microadhesiolysis Figure 5
Magnetic resonance images (MRI) of a patient before and 
after interventional microadhesiolysis. The joint effusion 
decreased after the patient underwent interventional micro-
adhesiolysis. (a) Axial and (c) coronal views of the shoulder 
MRI taken before intervention. (b) Axial and (d) coronal 
views of shoulder MRI taken after intervention.
Table 2: Mean pre- and post-interventional self-rated pain score 
or severity and range of motion (ROM) of the affected shoulder
Variable Pre Post p-value
Self-rated pain score or severity
Overalla (VAS) 7.6 ± 1.0 2.4 ± 1.8 .0020
Painb at night 4.2 ± 1.3 1.2 ± 0.6 .0039
Painb at rest 2.4 ± 1.0 1.2 ± 0.4 .0078
Painb on activity 3.6 ± 0.5 1.8 ± 0.4 .0020
Glenohumeral range of motion 
(deg)
Abduction 86.5 ± 5.8 172.0 ± 11.4 .0020
External rotation 33.0 ± 6.3 77.5 ± 17.2 .0020
Internal rotation 16.5 ± 4.7 49.5 ± 10.1 .0020
aEvaluated using the visual analogue scale (VAS) pain score.
bEvaluated using the self-rated severity of pain (1 = none, 2 = mild, 3 = 
moderate, 4 = severe, 5 = very severe pain).BMC Musculoskeletal Disorders 2008, 9:12 http://www.biomedcentral.com/1471-2474/9/12
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supraspinatus muscle and subacromial bursa were
released during the subacromial release procedure. The
coracohumeral ligament, rotator interval (the triangular
portion of the shoulder capsule lying between the
supraspinatus and subscapularis tendons), and subscapu-
laris muscle were approached and released during the sub-
coracoid release procedure. The rotator interval was
reached by a needle when the patient's shoulder was
adducted, externally rotated, and extended 15–30°.
Follow-up MRI showed that joint effusion decreased or
disappeared. The increased shoulder mobility after the
intervention might have contributed to this finding. How-
ever, no significant change was noted in the thickening of
the IGHL. Although the clinical condition of the patients
improved, it might take more time to regenerate collagen
and the follow-up period for MRI might be insufficient to
detect overt changes in the thickness of the IGHL.
Three patients underwent one intervention only, six
patients underwent two interventions, and one patient
underwent three interventions. In our clinical experience,
the treatment outcomes of those who had an underlying
partial rotator cuff tear or biceps tendinopathy combined
with adhesive capsulitis were not favorable and they
needed more than one intervention. We also postulate
that the underlying shoulder instability contributed to the
unfavorable outcome of the initial treatment.
We recommend that all of the procedures in interven-
tional microadhesiolysis for adhesive capsulitis of the
shoulder be performed in sequence. The sequential com-
bination of all three release procedures enables full ROM
of the affected shoulder joint in all directions.
Interventional microadhesiolysis has several advantages
compared to other interventions for adhesive capsulitis.
Although this technique is invasive, it is minimally so. A
skilled operator and assistant can perform this technique
in 30 min for unilateral shoulder. Pre-interventional clin-
ical laboratory tests and imaging diagnosis can be
obtained at outpatient clinics and the patient need not be
hospitalized for this treatment. Operators can control the
extent of adhesiolysis using the specially made needles for
interventional microadhesiolysis. We believe that the
characteristics of the specially made needles – streamlined
shape, being solid but flexible, and having a round, blunt
tip – enable the operators target the lesion accurately,
reach a wide area, and allow the minute release of adhe-
sions, while minimizing unwanted tissue damage. As in
other invasive interventions, we caution that the contrain-
dications of interventional microadhesiolysis include, for
example, pregnancy, bleeding tendency, and generalized
weakness.
This study was a case series, which poses a limitation,
although we observed favorable treatment results. Thus,
further studies or randomized clinical trials are needed to
evaluate the efficacy of interventional microadhesiolysis
compared to other treatment methods for adhesive capsu-
litis of the shoulder.
Conclusion
Interventional microadhesiolysis was developed to release
adhesions in joints and soft tissues. The procedure was
used to treat 10 patients with primary adhesive capsulitis
of the shoulder. Three specially made needles (i.e., Round,
Flexed Round, and Ahn's Needles) and three release
approaches (i.e., subacromial, posteroinferior capsule,
and subcoracoid release) were used in interventional
microadhesiolysis. After the patients underwent interven-
tional microadhesiolysis, selected outcome measures (i.e.,
self-rated pain score or severity, range of motion, and joint
effusion on MRI) were improved compared to their initial
status. Thus, interventional microadhesiolysis is effective
to manage adhesive capsulitis of the shoulder.
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